Sinaptica Therapeutics has filed an intent-to-use trademark application (TM90833782) with the USPTO for medical equipment. The application specifically covers magnetic neuromodulators and medical apparatus intended for the treatment of central nervous system, psychiatric, and neurological disorders through noninvasive brain stimulation, including transcranial magnetic stimulation machines. The application explicitly excludes uses related to pain treatment.

This filing indicates Sinaptica Therapeutics' intent to use these marks in commerce for the specified medical equipment. While this is a trademark application and not a regulatory approval, it signals a potential new market entrant or product line in the medical device sector focused on neurological and psychiatric treatments. Compliance officers in this sector should note this development as it may indicate future product launches or market activity.